INTERNATIONAL PATENT: CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, 차의과학대학교 산학협력단, SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING BOMBYX MORI POWDER OR SILK FIBROIN-DERIVED PEPTIDE"

GENEVA, April 29 -- CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (120 Haeryong-roPocheon-siGyeonggi-do 11160), 차의과학대학교 산학협력단 (경기도포천시해룡로 120), SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566) filed a patent application (PCT/KR2025/016156) for "PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING BOMBYX MORI POWDER OR SILK FIBROIN-DERIVED PEP...